Clinical Trial Update: Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [Phase 3]

View source ↗

Summary

Phase 3 trial update on Herceptin followed by chemotherapy for metastatic HER2-overexpressing breast cancer; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED